Jason E. Tester, Director, 10% Owner at Tarsus Pharmaceuticals, Inc. (TARS), bought 193,450 shares at $16.00 ($2.8M) on 2020-10-20, disclosed to the SEC on 2020-10-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 21,575 | $0 | 0.0% |
| 2 | $16.00 | 3,125 | $50K | 1.8% |
| 3 | $16.00 | 168,750 | $2.7M | 98.2% |
| Total | $14.22 avg | 193,450 | $2.8M | 100% |